SIA ZIM Laboratories Limited specializes in providing a wide range of differentiated and complex generic Pharmaceutical and Nutraceutical products under Pre-Formulation Intermediates (PFI) and Finished Formulations (FF) to our customers worldwide. Our offerings consist of DC (Directly Compressible) granules, pellets (sustained, modified, extended-release), taste-masked powders, suspensions, tablets, capsules, and Oral Thin Films (OTF), which are based on our patented Thinoral® technology.

We strive to offer our customers an affordable, science-driven, and all-encompassing range of pharmaceutical products that target a wide spectrum of therapeutic segments such as Cardiovascular Diseases, Anti-infectives, Gastrointestinal Disorders, Respiratory Illnesses, Urology, Nervous System disorders, Musculoskeletal problems, NSAID/Pain Management, and Hematology. We carefully formulate and rigorously test our products to ensure the highest quality and efficacy, thus contributing to the overall well-being of the patients we serve.

New Innovative Products (NIP):

ZIM has cultivated an exclusive pipeline of New Innovative Products (NIP), comprising complex generic products utilizing non-infringing development and differentiated drug delivery methods. Presently, we have developed 10 NIP, each progressing through various stages of dossier completion and registration.

At SIA ZIM Laboratories Limited, we strongly believe in a well-rounded and comprehensive approach to healthcare, with a focus on the end customer’s wellbeing. Therefore, we strive to deliver world-class, research-based, and highly effective Nutraceutical products and healthcare supplements designed to address a wide range of health issues, including lifestyle diseases, nutritional deficiencies, and other related ailments. We are committed to providing our customers with the best possible healthcare solutions to help them lead healthier, more fulfilling lives.